Clinical Trial

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 15, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to compare the real-life effectiveness and safety of vedolizumab, ustekinumab and JAK inhibitors in patients with UC who had been exposed to at least one anti-TNF-alpha therapy.
Trial Details
NCT Number NCT06691061
Lead Sponsor Humanitas Clinical and Research Center
Conditions Ulcerative Colitis (Disorder)
Enrollment 450 participants
Start Date 2023-08-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-15